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Intraventricular hemorrhage (IVH) is a frequent complication of prematurity that is
associated with high neonatal mortality and morbidity. IVH is accompanied by red
blood cell (RBC) lysis, hemoglobin (Hb) oxidation, and sterile inflammation. Here we
investigated whether extracellular Hb, metHb, ferrylHb, and heme contribute to the
inflammatory response after IVH. We collected cerebrospinal fluid (CSF) (n = 20) from
premature infants with grade III IVH at different time points after the onset of IVH. Levels
of Hb, metHb, total heme, and free heme were the highest in CSF samples obtained
between days 0 and 20 after the onset of IVH and were mostly non-detectable in CSF
collected between days 41 and 60 of post-IVH. Besides Hb monomers, we detected
cross-linked Hb dimers and tetramers in post-IVH CSF samples obtained in days 0–20
and 21–40, but only Hb tetramers were present in CSF samples obtained after 41–
60 days. Vascular cell adhesion molecule-1 (VCAM-1) and interleukin-8 (IL-8) levels
were higher in CSF samples obtained between days 0 and 20 than in CSF collected
between days 41 and 60 of post-IVH. Concentrations of VCAM-1, intercellular adhesion
molecule-1 (ICAM-1), and IL-8 strongly correlated with total heme levels in CSF. Applying
the identified heme sources on human brain microvascular endothelial cells revealed
that Hb oxidation products and free heme contribute to the inflammatory response. We
concluded that RBC lysis, Hb oxidation, and heme release are important components
of the inflammatory response in IVH. Pharmacological interventions targeting cell-
free Hb, Hb oxidation products, and free heme could have potential to limit the
neuroinflammatory response following IVH.
Keywords: intraventricular hemorrhage, hemoglobin, heme, premature infants, cerebrospinal fluid, adhesion
molecules, brain endothelial cell, inflammation
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INTRODUCTION
Intraventricular hemorrhage (IVH) is a frequent complication
of prematurity, occurring in about 15% to 20% of very low
birth-weight (<1,500 g) preterm infants, and its incidence is
even higher (∼45%) in extremely low birth-weight infants
(500–750 g) (1–3). IVH is associated with high neonatal
mortality (20–50%) and increases the risk of neurodevelopmental
impairment in the surviving infants beyond the risk associated
with prematurity alone (4).
During fetal brain development, neurons and glial cells
migrate out from the germinal matrix (GM), a highly cellular and
vascularized layer of the brain. The GM is most active between 8
and 28 gestational weeks, and generally absent in term infants (5).
In preterm infants, IVH results from bleeding of the GM, because
its capillary network is extremely fragile, and unable to regulate
cerebral blood flow (6).
IVH in preterm infants leads to systemic inflammation,
characterized by elevation of pro-inflammatory cytokines, e.g.,
tumor necrosis factor alpha (TNF-α), interleukin-8 (IL-8),
IL-1β, chemokines such as monocyte adhesion molecule-1, and
increased levels of adhesion molecules, i.e., vascular cell adhesion
molecule-1 (VCAM-1) and intercellular adhesion molecule-1
(ICAM-1) (7). As a sign of local inflammatory response, the
levels of E-selectin, VCAM-1, ICAM-1, and L-selectin were found
to be elevated in the cerebrospinal fluid (CSF) of patients after
subarachnoid hemorrhage (8).
Rupture of the microvasculature of the GM causes
extravasation of red blood cells (RBCs) in the CSF followed
by lysis of RBCs. While hemoglobin (Hb) is compartmentalized
in RBCs, its oxidation is prevented by a highly effective
antioxidant defense system including enzymatic (Cu/Zn
superoxide dismutase, catalase, glutathione peroxidase, and
peroxiredoxins) and non-enzymatic (glutathione) scavengers
[reviewed in Jeney et al. (9)]. In contrast, outside RBCs, Hb is
prone to oxidation, giving rise to the formation of different Hb
oxidation products [metHb (Fe3+), ferrylHb (Fe4+ = O2−)] and
subsequent release of heme. The formed high-valence (Fe4+)
iron compounds are reactive intermediates and decay quickly
via intramolecular electron transfer between the ferryl iron and
specific amino acid residues of the globin chains resulting in the
formation of globin radicals (10). Then the termination of the
reaction occurs when these globin radicals react with each other
leading to the formation of covalently cross-linked Hb multimers
[reviewed in Jeney et al. (9)]. Covalently cross-linked oxidized
Hb forms have been detected in different biological samples
including plasma following intravascular hemolysis as well as
in human complicated atherosclerotic lesions with intraplaque
hemorrhage (11, 12).
Oxidized Hb forms (metHb, ferrylHb) and labile heme exert
diverse pro-oxidant and pro-inflammatory activities toward
different cell types including endothelial cells (ECs). As pro-
oxidants, they induce lipid peroxidation and sensitize ECs
to oxidant-mediated killing (13, 14). Heme induces toll-like
receptor 4 (TLR4) activation and subsequent upregulation
of adhesion molecules VCAM-1, ICAM-1, and E-selectin
in ECs (15).
Besides heme, ferrylHb but not Hb or metHb induces
upregulation of adhesion molecules in ECs, but interestingly,
this response is not dependent on TLR4 activation (16).
Increased endothelial permeability contributes to inflammatory
cell extravasation upon hemolysis, and previous studies showed
that ferrylHb and free heme induce the loss of endothelial
integrity (16–20).
The goal of the present study was to perform a qualitative
and quantitative analysis of the Hb content of human CSF
samples obtained from premature infants following IVH with
a special interest in detecting ferrylHb/covalently cross-linked
Hb species. We also aimed to investigate the pro-oxidant and
pro-inflammatory effects of these Hb forms on human brain
microvascular endothelial cells (HBECs). We determined the
levels of inflammatory markers in post-IVH CSF samples and
correlated their values to the heme content of CSF samples
to further understand the role of heme in triggering the
inflammatory response following IVH. We believe that a better
understanding of the molecular mechanism of the post-IVH
inflammatory response is critical in tailoring therapeutic tools
to avoid these infants from the development of the life-long
neurological effects of IVH.
MATERIALS AND METHODS
Materials
Reagents were purchased from Sigma-Aldrich (St. Louis, MO,
United States) unless otherwise specified.
Patient Selection and CSF Collection
In this study, we used the leftover of CSF samples that
were collected by spinal tap or ventricular reservoir puncture
for diagnostic purposes at the Department of Neurosurgery,
University of Debrecen. Preterm infants (n = 20) diagnosed
with grade III IVH with a mean gestational age at birth of
27.9 ± 2.2 weeks were involved in the study. CSF samples were
collected at 26.6 ± 16.4 days after the onset of IVH. No CSF was
obtained exclusively for inclusion in this study. Within 30 min of
collection, CSF samples were centrifuged (2,000 g, 4◦C, 15 min),
and supernatants were stored aliquoted at −70◦C until analysis.
The procedures were approved by the Scientific and Research
Ethics Committee of the University of Debrecen and the Ministry
of Human Capacities under the registration number of 1770-
5/2018/EÜIG. Parental consent forms were signed by the parents
of the infants involved in this study.
Determination of Hb, metHb, ferrylHb,
Total Heme, Free Heme, and Bilirubin
Levels in CSF
The absorbance spectra (250–700 nm) of CSF samples were
taken with a spectrophotometer (NanoDrop 2000, Thermo Fisher
Scientific, MA, United States). Concentrations of Hb, metHb, and
ferrylHb were calculated from the absorbance values measured
at 541, 576, and 630 nm, using the absorption coefficients and
equations determined previously by Meng and Alayash (21). The
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total heme concentration of CSF samples was determined by
using a QuantiChrom Heme Assay Kit (Gentaur Ltd., London,
United Kingdom) according to the manufacturer’s instructions.
Concentration of non-Hb bound heme was calculated by the
following equation: [free heme] = [total heme] – [Hb-heme] –
[metHb-heme] – [ferrylHb]. Bilirubin levels in CSF samples were
measured by a colorimetric assay on a Cobas 6000 analyzer
(Roche Diagnostics, Mannheim, Germany).
Cell Culture
HBEC cell line was purchased from ATCC (CRL-3245, Manassas,
VA, United States). Cells were cultured in Media 199,
supplemented with 10% fetal bovine serum (Gibco, Waltham,
MA, United States), 40 µg/ml EC growth supplement, and 1%
penicillin/streptomycin in 5% CO2 humidified atmosphere at
37◦C. HBECs were used at passages 5 and 8.
Hemoglobin Preparation
We prepared Hb, metHb, and ferrylHb from fresh blood obtained
from healthy volunteers as described in detail in our previous
work (12). Briefly, Hb was isolated from fresh blood drawn
from healthy volunteers using ion-exchange chromatography
on a DEAE Sepharose CL-6B column. metHb was generated
by incubation (30 min, 25◦C) of purified Hb with a 1.5-fold
molar excess of K3Fe(CN)6 over heme. FerrylHb was obtained by
incubation (1 h, 37◦C) of Hb with a 10:1 ratio of H2O2 to heme.
The ferryl state of iron is highly unstable and therefore ferrylHb
transiently forms. During stabilization of ferryl iron, different
chemically heterogeneous oxidized Hb molecules are formed,
which we refer to as ferrylHb to reflect rather the way of their
formation than their actual oxidation status. After oxidation,
both metHb and ferrylHb were dialyzed against saline (three
times for 3 h at 4◦C) and concentrated using Amicon Ultra
centrifugal filter tubes (10,000 MWCO, Millipore Corp., Billerica,
MA, United States). Aliquots were snap-frozen in liquid nitrogen
and stored at−70◦C until use.
Cell Viability Assay
Confluent HBECs grown in 96-well tissue-culture plates were
washed twice with Hank’s Balanced Salt Solution (HBSS) and
exposed to heme and different Hb species (Hb, metHb, or
ferrylHb at a concentration of 10–100 µmol/L heme group) for
24 h. Then cells were washed with HBSS, and 100 µl of 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT)
(0.5 mg/ml) solution in HBSS was added. After a 4-h incubation,
the MTT solution was removed, formazan crystals were dissolved
in 100 µl of dimethyl sulfoxide, and optical density was
determined at 570 nm.
Endothelial Cell Monolayer Integrity
Assay
The electric cell-substrate impedance sensing (ECIS) method
was used to measure the endothelial monolayer integrity.
HBECs were cultured in 8-well electrode arrays (8W 10E,
Applied BioPhysics Inc., Troy, NY, United States). After reaching
confluence, cells were treated with different Hb species (Hb,
metHb, and ferrylHb at a concentration of 50µmol/L heme), and
the complex impedance spectrum was monitored with an ECIS
Zθ instrument (Applied BioPhysics Inc., Troy, NY, United States)
for 4 h. Results are shown as the difference between monolayer
resistance at 4,000 Hz at 0 time point and 4 h.
Quantitative Real-Time PCR
Total RNA was isolated from HBECs using TRizol (RNA-
STAT60, Tel-Test Inc., Friendswood, TX, United States)
according to the manufacturer’s protocol. Two micrograms
of RNA was reverse-transcribed to cDNA with a High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Waltham, MA, United States). PCR was performed using iTaq
Universal Probes Supermix (BioRad Laboratories, Hercules, CA,
United States) and predesigned primers and probes (TaqMan R©
Gene Expression Assays) VCAM-1 (Hs01003372), ICAM-1
(Hs00164932), HO-1 (Hs01110250), IL-8 (Hs00174103), and
GAPDH (Hs0278624). Relative mRNA expressions were
calculated with the 11Ct method using GAPDH as an
internal control.
Intracellular ROS Measurement
ROS production was monitored by using the 5-(and-6)-
chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate, acetyl
ester (CM-H2DCFDA) assay (Life Technologies, Carlsbad, CA,
United States). Confluent HBECs were exposed to the Hb forms
Hb, metHb, ferrylHb, and heme (10, 25, 50, and 100 µmol/L
heme) for 4 h in M199 media supplemented with 1% FBS. Then
cells were loaded with CM-H2DCFDA (10 µmol/L, 30 min,
at 37◦C in the dark), followed by three washes with HBSS.
Fluorescence intensity was measured every 30 min for 4 h
applying 488-nm excitation and 533-nm emission wavelengths.
Western Blot
Whole cell lysates (20 µg/lane) or CSF samples (5 µl/lane) were
resolved on 10% SDS-PAGE, then blotted onto a nitrocellulose
membrane (Amersham Proton 1060003, GE Healthcare,
Chicago, IL, United States). Western blot was performed with
the use of the following polyclonal antibodies: anti-HO-1
antibody (70081, Cell Signaling Technology Inc., Danvers, MA,
United States) at a concentration of 50 ng/ml and anti-VCAM-1
antibody (Sc-8304, Santa Cruz Biotechnology, Inc., Dallas, TX,
United States) at a concentration of 1 µg/ml. We used peroxidase
labeled anti-rabbit IgG (NA931, Amersham Bioscience,
Piscataway, NJ, United States) as a secondary antibody at a
concentration of 20 ng/ml. For Hb detection, we used an HRP-
conjugated goat antihuman Hb polyclonal antibody (ab19362-1,
Abcam Plc., Cambridge, United Kingdom) at a concentration
of 0.1 µg/ml. Antigen–antibody complexes were visualized
with the horseradish peroxidase chemiluminescence system
(Amersham Biosciences Corp., Piscataway, NJ, United States).
Chemiluminescent signals were detected conventionally on an
X-ray film or digitally by using a C-DiGit Blot Scanner (LI-COR
Biosciences, Lincoln, NE, United States). After detection, the
membranes were stripped and re-probed for β-actin using
HRP-conjugated anti-β-actin antibody (Sc-47778, Santa Cruz
Biotechnology, Inc., Dallas, TX, United States) at a concentration
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of 0.13 µg/ml. Blots were quantified by using the inbuilt software
of the C-DiGit Blot Scanner (LI-COR Biosciences, Lincoln,
NE, United States).
Measurement of Soluble VCAM-1,
ICAM-1, and IL-8 Levels in CSF Samples
To perform enzyme-linked immunosorbent assay (ELISA),
CSF samples were first centrifuged at 10,000 g for 1 min.
Soluble VCAM-1 and ICAM-1 protein concentrations
were quantitatively measured by ELISA as described in the
manufacturer protocol (R&D Systems, Minneapolis, MN,
United States). Levels of IL-8 were determined by ELISA (BD
OptEIA; BD Biosciences, San Diego, CA, United States).
Statistical Analysis
Results are expressed as mean ± SD. At least three independent
experiments were performed for all in vitro studies. Statistical
analyses were performed with GraphPad Prism software (version
8.01, San Diego, CA, United States). Comparisons between more
than two groups were carried out by ordinary one-way ANOVA
followed by post hoc Tukey’s multiple-comparisons test. We
applied one-way ANOVA followed by Dunnett’s post hoc test
when experimental groups were compared to a control. A value
of p < 0.05 was considered significant. To measure the strength
of the association between two variables, we performed Pearson’s
correlation analysis. A strong positive correlation was defined as
a value of Pearson’s correlation coefficient (r)> 0.4.
RESULTS
Time-Dependent Accumulation of
Different Oxidized Hb Forms, Free Heme,
and Bilirubin in Post-IVH CSF Samples
In this study, we have analyzed 20 CSF samples that were
collected by spinal tap or ventricular reservoir puncture from
preterm infants diagnosed with grade III IVH. The main
characteristics of the patients are summarized in Table 1. All
patients were preterm infants with a median gestational age of
28 weeks at delivery (Table 1). The mean birth weight of the
infants was 1,094 ± 282 g (Table 1). Out of the 20 infants, 10
did not receive steroid prophylaxis, and 8 obtained partial steroid
prophylaxis. In addition, 14 infants were born via Cesarean
section, 18 developed hydrocephalus, and 2 of them died before
6 months of age (Table 1).
Because CSF samples were taken for diagnostic purposes, we
obtained CSF samples at different time points after the onset of
IVH (days 14–60, mean: 27.6 ± 15.6 days, median: 21 days).
Based on the elapsed time between the onset of IVH and CSF
sampling, we divided the samples into three groups, 0–20 days,
21–40 days, and 41–60 days. CSF samples obtained at different
time intervals after the onset of the IVH had different colors, i.e.,
0–20 days CSF samples had brownish discoloration, 21–40 days
CSF samples were yellowish, whereas 41–60 days CSF samples
were colorless similar to a normal CSF specimen (Figure 1A).
To evaluate Hb, metHb, and ferrylHb concentrations in CSF,
TABLE 1 | Characteristics of the patients.
Characteristic Grade III IVH (n = 20)
Male sex - no./total no. 11/20
Gestational age at delivery
Median - week
Distribution
23 week 0 days to 25 week 6 days
26 week 0 days to 27 week 6 days
28 week 0 days to 29 week 6 days
30 week 0 days to 31 week 6 days
28
4
4
6
6
Birth weight
Mean ± s.d. - g
Distribution
≥500 to <750 g
≥750 to <1000 g
≥1000 to <1250 g
≥1250 to <1500 g
1094 ± 282
3
6
4
7
Apgar 5 min
Median
Distribution
0–3
4–6
7–8
9–10
5
4
13
3
0
Apgar 10 min
Median
Distribution
0–3
4–6
7–8
9–10
8
0
7
9
4
Steroid prophylaxis - yes/partial/no 2/8/10
Multiply pregnancy - no./total no. 5/20
Cesarean section delivery - no./total no. 14/20
Hydrocephalus - no./total no. 18/20
Death - no./total no. 2/20
Timing of the CSF samples [days after
the onset of IVH, (n)]
14(1), 15(1), 16(1), 17(2), 19(1),
20(2), 21(4), 24(1), 25(1), 28(1),
32(1), 45(1), 60(3)
CSF samples were collected from premature infants (n = 20) diagnosed with grade
III IVH.
we took the visible absorption spectra of the samples and
calculated Hb concentrations with the use of molar extinction
coefficients as determined previously (21). The Hb levels of CSF
samples obtained 0–20 days after the onset of IVH showed a big
variation from 13.08 up to 228.12 µmol/L, with an average of
85.04 ± 72.38 µmol/L. The Hb concentration in CSF samples
obtained at later time points, i.e., 21–40 days after IVH onset,
was significantly lower (7.61 ± 10.32 µmol/L), and Hb was
undetectable in CSF samples collected 41–60 days following
IVH (Figure 1B).
One-electron oxidation of Hb leads to the formation of
metHb. Similarly to that of Hb, we found high amounts of metHb
in CSF samples obtained at 0–20 days (80.51 ± 77.65 µmol/L),
which decreased gradually during the study period (Figure 1C).
On average, metHb concentration was 9.65 ± 10.77 µmol/L in
CSF samples obtained at 21–40 days after the onset of IVH and
was below the detection limit in CSF samples collected after 41–
60 days of IVH (Figure 1C). Two-electron oxidation of Hb by
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FIGURE 1 | Time-dependent accumulation of Hb, metHb, and ferrylHb in
post-IVH CSF samples. CSF samples (n = 20) were obtained from preterm
infants diagnosed with grade III IVH at different time intervals after the onset of
IVH. (A) Physical appearance of CSF samples obtained at different time
intervals after the onset of IVH (days 0–20, 21–40, 41–60). (B–D)
Concentrations of Hb, metHb, and ferrylHb were quantified
spectrophotometrically in CSF samples. Closed circles represent individual
samples, red circles represent patients that died before 6 months of age, and
bars represent mean ± SD values. P-values were calculated using one-way
ANOVA followed by Tukey’s multiple comparison analysis. *p < 0.05.
peroxides, for instance, could lead to the formation of ferrylHb.
Interestingly, we could hardly detect any ferrylHb in the CSF
samples, which could be explained by the highly unstable nature
of this Hb species (Figure 1D).
FerrylHb is a reactive intermediate that decays quickly via
intramolecular electron transfer between the ferryl iron and
specific amino acid residues of the globin chains. In this reaction,
globin radicals are produced, which are still unstable and react
with each other to get stabilized via the formation of covalent
bonds between the globin subunits (9). Next we addressed
whether this occurs following IVH in the CSF. We have analyzed
all the CSF samples by western blot under reducing conditions
and detected Hb forms with different molecular weights that
corresponded as globin monomers (16 kDa), dimers (32 kDa),
and tetramers (Hb) (64 kDa). A representative western blot
is shown in Figure 2A. Densitometric analysis of the western
blots revealed that in CSF samples obtained at 0–20 days after
the onset of IVH contained predominantly globin monomers
(59.3 ± 29.3% of total Hb), less globin dimers (33.6 ± 28.2% of
total Hb), and very low amounts of Hb tetramers (7.03 ± 11.1%
of total Hb) (Figures 2A,B). Interestingly, we observed a shift
toward the formation of globin dimers and tetramers in CSF
samples obtained at 21–40 days post-IVH (Figures 2A,B). This
change becomes highly remarkable in CSF samples obtained after
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FIGURE 2 | Time-dependent accumulation of covalently cross-linked globin
multimers in post-IVH CSF samples. Hb contents of CSF samples (n = 20)
obtained from preterm infants diagnosed with grade III IVH at different time
intervals after the onset of IVH were analyzed by western blot.
(A) Representative western blot is shown. (B) Densitometric analysis of
western blots of all samples (n = 20) was performed and percentage of globin
monomers, dimers, and tetramers (Hb) is presented as mean ± SD. P-values
were calculated using one-way ANOVA followed by Tukey’s multiple
comparison analysis. *p < 0.05, **p < 0.01, ****p < 0.001.
41–60 days of IVH, as these samples contained neither monomers
nor dimers but contained Hb tetramers (Figures 2A,B).
Hb oxidation can lead to the dissociation of the heme group
from the globin giving a rise in the formation of non Hb-bound
(free) heme. To see whether this occurred following IVH, first
we determined total heme levels in CSF samples. Total heme
levels were very high in CSF obtained at 0–20 days after the
onset of IVH ranging from 120.02 up to 1,035.27 µmol/L with
an average of 463.01 ± 303.39 µmol/L (Figure 3A). Total heme
levels were significantly lower in CSF samples obtained at 21–
40 days after the onset of IVH (64.98 ± 73.50 µmol/L) and
was below 1 µmol/L in CSF samples collected 41–60 days post-
IVH (Figure 3A). Correlation analysis between Hb and total
heme levels revealed a very strong linear correlation (r = 0.7296)
between the two variables, suggesting that Hb is the major
source of heme in CSF as we expected (Figure 3B). Next we
calculated the concentration of free heme as described in the
methods. Free heme concentrations were high in CSF collected
at 0–20 days after the onset of IVH ranging from 41.99 to
717.39 µmol/L with an average of 295.34 ± 259.80 µmol/L
(Figure 3C). Free heme levels were significantly lower in
CSF samples obtained at 21–40 days after the onset of IVH
(47.73 ± 57.50 µmol/L) and was below 1 µmol/L in CSF
samples collected 41–60 days post-IVH (Figure 3C). We looked
at the correlation between the concentration of oxidized Hb
(metHb + ferrylHb) and free heme and found a strong positive
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FIGURE 3 | Time-dependent accumulation of total heme, free heme, and bilirubin in post-IVH CSF samples. CSF samples (n = 20) were obtained from preterm
infants diagnosed with grade III IVH at different time intervals (days 0–20, 21–40, 41–60) after the onset of IVH. (A,C,E) Total heme, free heme, and bilirubin levels of
CSF samples were determined. Closed circles represent individual samples, red circles represent patients that died before 6 months of age, and bars represent
mean ± SD. P-values were calculated using one-way ANOVA followed by Tukey’s multiple comparison analysis. *p < 0.05, **p < 0.01. (B,D,E) Correlation between
(B) Hb and total heme concentrations, (D) oxidized Hb forms (MHb + FHb) and free heme concentrations, and (F) total heme and bilirubin concentrations in
post-IVH CSF samples (n = 20) is shown. R represents Pearson’s correlation coefficient.
correlation (r = 0.4809) between the two variables, which
supports the concept that oxidized Hb forms can release their
heme prosthetic groups (Figure 3D). Additionally, we measured
the concentration of bilirubin, one of the end-products of heme
catabolism in CSF samples. We found that bilirubin levels
were the highest (8.8 ± 2.47 µmol/L) in CSF collected at 0–
20 days after the onset of IVH, and then it gradually decreased
in time (Figure 3E). We found that bilirubin levels strongly
correlated to the total heme levels in post-IVH CSF samples
(r = 0.7568) (Figure 3F).
Pro-oxidant and Pro-inflammatory
Effects of Hb Forms and Free Heme
Toward Human Brain Microvascular
Endothelial Cells
IVH in preterm infants leads to systemic inflammation
characterized by increased levels of pro-inflammatory cytokines
and cellular adhesion molecules. ECs play a critical role in the
pro-inflammatory responses, and Hb oxidation products have
been shown to be implicated in diverse hemolysis-associated
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sterile inflammatory reactions. Therefore, next we have addressed
the pro-oxidant and pro-inflammatory effects of the different
Hb oxidation products that were identified in post-IVH CSF
samples toward HBECs.
First we have addressed whether the different Hb forms induce
heme oxygenase-1 (HO-1), the stress-responsive inducible
enzyme that catalyzes heme degradation upon heme overload
conditions. We exposed HBECs to Hb, metHb (MHb), ferrylHb
(FHb), and free heme (25 µmol/L heme group). Oxidized Hb
forms, i.e., metHb and ferrylHb, induced an 18.2± 2.6-fold and a
12.1± 3.1-fold elevation of HO-1 mRNA levels (4 h), respectively
(Figure 4A). In contrast, native Hb did not cause an elevation
of HO-1 mRNA (Figure 4A). Free heme was a highly more
potent inducer of HO-1 in HBECs in comparison with metHb
and ferrylHb triggering a more than 1,000-fold elevation of the
HO-1 mRNA level after a 4-h exposure (Figure 4A). In parallel
with the changes of the HO-1 mRNA level, both metHb and
ferrylHb induced an about 20-fold elevation of the HO-1 protein
expression, whereas free heme increased the HO-1 expression by
about 200-fold (Figure 4B).
Heme is a catalyst of the Fenton reaction and therefore
is implicated in the sustained production of reactive oxygen
species (ROS) under hemolytic conditions. Next we investigated
whether the Hb oxidation products found in post-IVH CSF
samples induce ROS production in HBECs. HBECs were treated
with Hb, metHb, ferrylHb, and heme (10, 25, 50, 100 µmol/L
heme group) for 4 h, and ROS formation was measured as
described in the methods. Heme at concentrations of 50 and
100 µmol/L induced substantial production of ROS (Figure 5A).
In contrast, neither native Hb nor oxidized Hb forms (metHb
and ferrylHb) increased ROS production in HBECs (Figure 5A).
To see whether Hb oxidation products induce HBEC death,
we exposed the cells to Hb, metHb, ferrylHb, and free heme
(10, 25, 50, 100 µmol/L heme group) for 24 h. Heme at
concentrations of 50 and 100 µmol/L induced a substantial
reduction in cell viability (Figure 5B). On the contrary, cell
viability was unaffected by the Hb forms, even when they were
applied at the highest concentration (Figure 5B). A previous
study on human umbilical vein ECs showed that oxidized Hb
increased endothelial monolayer permeability (16). Therefore,
we investigated whether the Hb forms impair HBEC monolayer
integrity. We exposed HBECs to Hb, metHb, and ferrylHb
(50µmol/L heme group) and measured the changes of monolayer
resistance over a 4-h period of time (Figure 5C). HBEC
monolayer integrity was unaffected by native Hb or metHb
treatment. In contrast, ferrylHb treatment largely impaired
HBEC monolayer integrity (Figure 5C).
Heme and oxidized Hb forms have been shown to be
implicated in the immune response in hemolytic diseases. More
specifically, heme and ferrylHb have been shown to upregulate
the expression of cellular adhesion molecules including VCAM-1
and ICAM-1 in human umbilical vein ECs. Here we treated
HBECs with Hb, metHb, ferrylHb, and heme (25 µmol/L
heme group) and measured mRNA expressions (4 h) of
VCAM-1, ICAM-1, and the pro-inflammatory cytokine IL-
8 (Figures 6A–D). We used LPS (100 ng/ml) as a positive
control in these experiments. Free heme and ferrylHb triggered
HO-1
kDa
37−
β-actin
37−
50−
A
B hemeHb FHb− MHb
hemeHb FHb− MHb
H
O
-1
 e
xp
re
ss
io
n
(β
-a
ct
in
no
rm
. f
ol
d 
ch
an
ge
)
150
50
20
0
300
40
30
10
****
****
****
0
10
20
30
40
800
1600
8 0
40
10
16 0
30
20
0R
el
at
iv
e
H
O
-1
 m
R
N
A
le
ve
l
(fo
ld
 c
ha
ng
e)
hemeHb FHb− MHb
****
****
****
1
2
3
4
5
15
30
*
FIGURE 4 | Induction of HO-1 mRNA and protein expression by different Hb
forms in HBECs. Confluent HBECs (P5-8) were exposed to vehicle, Hb,
MetHb (MHb), ferrylHb (FHb), and heme (25 µmol/L heme group) in 1% FBS.
(A) Relative mRNA expression (4 h, mean ± SD) of HO-1 normalized to
GAPDH from three independent experiments performed in triplicates.
(B) HO-1 protein levels (16 h) were analyzed by western blot from whole cell
lysates. Membranes were re-probed for β-actin. Representative blots of three
independent experiments are shown. Densitometry analysis (mean ± SD) of
three independent experiments. (A,B) P-values were calculated using
one-way ANOVA followed by Dunnett’s post hoc analysis. *p < 0.05 and
****p < 0.001.
marked elevations of VCAM-1 mRNA (∼15–20-fold), whereas
the effect of native Hb and metHb was milder inducing about
5-fold increases of VCAM-1 (Figure 6A). We observed a
similar trend on the protein level, namely, ferrylHb and free
heme were more potent in inducing VCAM-1 expression than
native Hb and metHb (Figure 6B). Additionally, free heme
and ferrylHb but not native Hb and metHb induced elevations
of ICAM-1 and IL-8 mRNA levels (Figures 6C,D). We have
to note that the bioavailable heme concentrations in these
experiments were much lower than 25 µmol/L due to the
presence of specific (Hx) and non-specific (albumin) heme-
binding proteins present in the serum, which was applied at 1%
in these experiments.
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FIGURE 5 | Induction of ROS production and cell death by different Hb forms
in HBECs. (A) Confluent HBECs (P5-8) were exposed to vehicle, Hb, MetHb,
ferrylHb (FHb), and heme (10, 25, 50, 100 µmol/L heme group) in 1% FBS for
4 h, then ROS production was monitored by DCFDA assay for an additional
4 h. Graph shows ROS production (mean ± SD) at 4-h time point from three
independent experiments performed in quadruplicates. (B) Confluent HBECs
(P5-8) were exposed to vehicle, Hb, MetHb, ferrylHb (FHb), and heme (10, 25,
50, 100 µmol/L heme group) in 1% FBS and cellular viability (24 h) was
assessed by MTT assay. Graph shows cell viability as a percentage of viability
of vehicle-treated cells (mean ± SD) from three independent experiments
performed in quadruplicates. (C) HBECs cultured in 8-well ECIS plates were
exposed to Hb, metHb, and ferrylHb (FHb) (50 µmol/L heme group) in 1%
FBS containing media. The complex impedance spectrum was monitored
with an ECIS Zθ instrument for 4 h. Change in resistance (mean ± SD) was
calculated based on the difference between monolayer resistance at 4,000 Hz
at 0 time point and 4 h from three independent experiments performed in
triplicates. (A–C) P-values were calculated using one-way ANOVA followed by
Tukey’s multiple comparison analysis. ***p < 0.005, ****p < 0.001.
Correlations Between Levels of Heme
and Pro-inflammatory Markers in
Post-IVH CSF Samples
Previous studies showed that the levels of pro-inflammatory
markers including soluble adhesion molecules and inflammatory
cytokines are elevated in post-IVH CSF samples. Our in vitro
data suggested that Hb-derived heme may play a critical role
in the induction of the pro-inflammatory response. To address
this question, we measured VCAM-1, ICAM-1, and IL-8 levels
in post-IVH CSF samples (N = 20). VCAM-1 levels were the
highest in CSF samples obtained between 0 and 20 days after the
onset of IVH (305.11 ± 120.12 ng/ml) (Figure 7A). Comparing
to these samples, VCAM-1 levels were significantly lower in
CSF samples obtained at 41–60 days after the onset of IVH
(165.31 ± 56.51 ng/ml) (Figure 7A). Then we analyzed whether
there is a correlation between heme and VCAM-1 levels in the
post-IVH CSF samples, and we found a strong linear correlation
between the two variables (r = 0.5603) (Figure 7B). Next,
we determined the level of soluble ICAM-1 in post-IVH CSF
samples. We observed a decreasing trend of ICAM-1 levels, but
the differences were not significant (Figure 7C). On the other
hand, ICAM-1 levels correlated strongly (r = 0.5864) with total
heme concentrations in post-IVH CSF samples (Figure 7D).
Finally, we have measured the level of the pro-inflammatory
cytokine IL-8 in the post-IVH CSF samples. We found that IL-
8 levels were the highest in CSF samples obtained at 0–20 days
after the onset of IVH (3.92± 0.85µg/ml), and then we observed
a gradual decrease in IL-8 levels at 21–40 and 41–60 days after the
onset of IVH resulting in 2.19 ± 1.5 and 0.2 ± 0.29 µg/ml IL-8
concentrations, respectively (Figure 7E). Additionally, we found
a strong positive correlation between total heme concentration
and IL-8 levels in post-IVH CFS samples (r = 0.6768) (Figure 7F).
DISCUSSION
IVH is a frequent complication of prematurity that
associates with high neonatal mortality and increased risk
of neurodevelopmental impairment in the surviving infants
(1–4). It is known for a long time that inflammation plays
a critical role in the pathophysiology of IVH-induced brain
damage; however, the molecular mechanism by which IVH
stimulates the inflammatory response is not fully understood.
Extravasation of blood into the intraventricular space triggers a
cascade of events including the release of various vasoactive and
pro-inflammatory molecules from blood and the vascular system
[reviewed in Sercombe et al. (22)].
In this study, we performed a qualitative and quantitative
analysis of Hb content of human CSF samples obtained from
premature infants following IVH at different time points after
the onset of IVH to understand the kinetics of Hb release,
oxidation, and clearance. We investigated the pro-oxidant and
pro-inflammatory effects of the identified Hb forms on HBECs
to extend our understanding of the particular roles that these
species may play in the neuroinflammatory response following
IVH. We measured the levels of pro-inflammatory markers in
post-IVH CSF samples at different time points after the onset
of IVH to explore the kinetics of the inflammatory response and
investigated whether the inflammatory response correlates to the
extent of hemolysis.
We showed that after IVH Hb is released into the CSF
and Hb oxidation occurs leading to the formation of metHb,
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experiments. (A–D) P-values were calculated using one-way ANOVA followed by Dunnett’s post hoc analysis. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001.
ferrylHb, and covalently cross-linked oxidized globin multimers.
Previous studies showed that cell-free Hb and Hb metabolites
are present in CSF following different types of intracranial
hemorrhage including IVH (23–25). Particularly, metHb that is
produced in a one-electron oxidation of Hb was detected in
CSF samples obtained following IVH in preterm infants as well
as in an experimental rabbit model of IVH (23). On average,
the metHb level in the CSF samples obtained between days
0 and 20 after the onset of IVH was 80.51 ± 77.65 µmol/L,
which is in good agreement with the previously reported level
of metHb in CSF (∼ 40 µmol/L) on day 3 post-IVH in a rabbit
model (23).
Peroxides trigger a two-electron oxidation of Hb, leading to
the generation of ferrylHb in which the oxidation state of iron is
+4. This unstable form of oxidized Hb was detected in human
blood under physiologic and pathophysiologic conditions, but
whether this form is produced following IVH has never been
addressed (26–28). We could detect ferrylHb only in two out of
eight CSF samples obtained between days 0 and 20 after the onset
of IVH, which might be explained by the highly reactive nature
of the ferryl iron.
High-valent iron in ferrylHb promotes the oxidation of
definite amino acids of the globin chains and the subsequent
intermolecular cross-linking of the globin subunits (9, 29, 30).
Under in vivo conditions, these covalently cross-linked ferrylHb
species were detected in different biological samples including
plasma and urine following intravascular hemolysis as well as
in human complicated atherosclerotic lesions with intraplaque
hemorrhage (11, 12, 31). Here we showed for the first time that
covalently cross-linked oxidized globin multimers, i.e., dimers
and tetramers, are present in the CSF samples following IVH.
In the circulation, extracellular Hb is eliminated through
the haptoglobin (Hp)–CD163 scavenger pathway (32). First
extracellular Hb binds to Hp with extremely high affinity (Kd ∼
10-12 mol/L) (33), then Hb–Hp complexes are internalized via
CD163 receptors expressed on macrophages and monocytes (34).
Regarding the CNS, Hp is present in CSF, but because of its low
concentration, the Hb-binding capacity of CSF (∼100 µg Hb in
adults) is far below the Hb-binding capacity of plasma (∼5 g Hb)
(35). It has been shown that following IVH, Hb penetrates from
the intraventricular space to the periventricular white matter and
contributes to the development of IVH-associated brain injury.
Hb concentration of CSF samples obtained between days 0
and 20 after the onset of IVH showed a huge variation ranging
from 13 up to 228 µmol/L with an average of 85 µmol heme
groups/L. This corresponds to 10–530 mg of Hb in the 50-
ml volume of CSF in the infants, and although we are lacking
information about Hp levels in the CSF of premature infants, we
assume that in most CSF samples, the level of cell-free Hb exceeds
the Hb-binding capacity of CSF.
Once bound to Hp, Hb is protected from oxidation; therefore,
the presence of oxidized Hb forms, i.e., metHb and ferrylHb in
the post-IVH CSF samples support the idea that the level of Hb
overwhelms the Hb binding capacity of Hp in CSF following
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IVH. Moreover, covalently cross-linked oxidized Hb multimers
that formed upon Hb oxidation have limited affinity toward Hp;
therefore, these species might bypass the homeostatic control of
cell-free Hb (36).
In contrast to native Hb, MetHb as well as ferrylHb can
release their heme prosthetic groups (13, 14, 37). Heme is a
hydrophobic molecule, which allows its penetration through
cell membranes by passive diffusion, although recently, cell
surface and organelle-associated transporters were discovered
to facilitate the movement of heme between the different
cellular compartments [reviewed in Gozzelino (38)]. Heme
has long been considered as a pro-oxidant molecule (39),
and recently, its pro-inflammatory nature has been recognized
as well (40). The pro-oxidant reactivity of heme relies on
the ability of its iron atom to exchange electrons with
a variety of substrates. For example, interaction of heme
with H2O2 results in the formation of the highly reactive
hydroxyl radical in the Fenton reaction. Consequently, heme
sensitizes various cells to oxidant- or cytokine-mediated
killing (41, 42). Regarding cells of the central nervous
system (CNS), heme (5–40 µmol/L) has been shown to
be cytotoxic toward astrocytes (43) and neurons (44), and
sensitize oligodendrocytes to TNF-α mediated programmed cell
death (42).
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To see whether there is any non Hb-bound, so-called “free”
heme in the post-IVH CSF samples, first we determined the
total heme concentration in CSF (total heme = heme in all Hb
forms+ free heme), and then calculated the amount of free heme.
We found a big individual variation in free heme levels in CSF
samples obtained between days 0 and 20 after the onset of IVH
ranging from 42 up to 717 µmol/L.
Intravascular free heme is eliminated by the CD91–heme–
hemopexin scavenging system [reviewed in Smith and McCulloh
(45)]. Hemopexin binds heme with the highest affinity of any
known protein (46), inhibits its catalytic activity, and facilitates
its removal via the CD91 receptor (47). The same CD91–heme–
hemopexin route exists in the CNS and plays an important role
in heme detoxification after subarachnoid hemorrhage in adults
influencing the clinical outcome (48). We have no information
whether the CD91–heme–hemopexin scavenging system has
evolved fully in preterm infants or the heme removal capacity
of such a system upon IVH, but in any case, we assume that the
system is oversaturated and this contributes to the accumulation
of free heme in the CSF after IVH.
Hb, metHb, total heme, and free heme levels were lower in CSF
samples collected at later time points between days 21 and 40 after
the onset of IVH in comparison to CSF samples collected during
the first 20 days following IVH. This suggests that although the
Hb and heme scavenging capacity of the CSF was overwhelmed
right after the onset of IVH, a slow clearing procedure took place
afterward. In CSF samples collected between days 41 and 60 after
the onset of IVH, we could hardly detect heme in any form. CSF
is renewed four to five times a day in adults, and this rate is
considered to be even higher in neonates. CSF is cleared via the
blood–CSF barrier through specific proteins that are expressed
in the choroid plexus epithelial cells that provide transport of
nutrients and ions into the CNS and removal of waste products
and ions from the CSF. Clearance for Hb and its derivatives from
CSF via the blood–CSF barrier could be an option following IVH,
but this mechanism has not yet been characterized.
FerrylHb is stabilized by intermolecular electron transfer
between the ferryl iron and an adjacent amino acid of the
globin chain resulting in globin radicals. The formed globin-
based radicals react with each other and form covalently cross-
linked Hb multimers that we could detect in CSF samples.
Interestingly, we found a clear shift toward the formation of
higher multimers at later time points after the onset of IVH. In
CSF obtained between days 21 and 40 after the onset of IVH, we
found significantly more covalently cross-linked oxidized globin
tetramers than in CSF collected earlier (days 0–20). Moreover,
in the CSF samples collected between days 41 and 60 after the
onset of IVH, we could detect exclusively the covalently cross-
linked oxidized globin tetramers. Considering that we could not
detect any heme in these samples, we concluded that these globin
tetramers have already released their heme prosthetic groups. The
presence of this form of Hb at days 41–60 after the onset of IVH
suggests that there is no efficient mechanism in the CNS for the
elimination of this oxidized Hb form.
The blood–brain barrier (BBB) prevents blood cells and
pathogens from entering the brain parenchyma and regulates
the transport of molecules between the plasma and the CNS
(49). Intracerebral hemorrhage (ICH) is associated with BBB
dysfunction, and several studies showed that blood components
(e.g., thrombin, Hb, iron) play a major role in ICH-induced
BBB dysfunction (50). The BMEC monolayer is an important
component of the BBB, and in a critical manner contributes to the
neuroinflammatory response mainly by inducing the leukocyte
adhesion cascade to facilitate the transmigration of inflammatory
cells into the CNS. Therefore, we investigated the effect of the
identified Hb forms in post-IVH CSF samples on BMECs.
Free heme content of CSF obtained between days 0 and 20
after the onset of IVH was particularly high; only one out of
eight CSF samples had a free heme content below 50 µmol/L,
three samples had high free heme content (50–250 µmol/L),
and four out of the eight CSF samples had very high free heme
content that exceeded 250 µmol/L. We showed here that heme
at the concentration of 50 µmol/L or higher causes BMEC
death due to elevated production of ROS. On the other hand,
neither native Hb nor the oxidized Hb forms triggered ROS
production or EC death.
With the use of a guinea pig exchange transfusion model, it
was previously shown that polymerized cell-free Hb triggers BBB
disruption (51). Additionally, we showed earlier that ferrylHb
induces intermolecular gap formation in HUVECs leading to
decreased endothelial monolayer integrity (16). In agreement
with the previous study, here we found that ferrylHb but not
native Hb or metHb impairs BMEC monolayer integrity.
HO-1, the oxidative stress-responsive enzyme that catalyzes
heme degradation, is induced following ICH in different cells of
the CNS including astrocytes, microglia, and ECs (52). Here we
showed that besides sublethal concentration of heme, oxidized
Hb forms, i.e., metHb and ferrylHb induce HO-1 expression.
HO-1 has antioxidant and anti-inflammatory actions and affords
protection against programmed cell death and inhibits the
pathogenesis of a variety of immune-mediated inflammatory
diseases (42). In line with this notion, it was shown that the
upregulation of HO-1 prevents the development of experimental
cerebral malaria in mice and attenuates BBB disruption and
neuroinflammation (53). These beneficial effects are considered
to be mediated by the binding of carbon monoxide (CO) – the
end-product of HO-1 activity – to Hb, preventing its oxidation
and the generation of free heme (53).
Recent studies showed the beneficial effect of CO gas
as well as CO releasing molecules (CORMs) in ICH.
CO/CORM treatment alters the inflammatory response,
attenuates vasospasm, improves neurobehavioral function,
preserves the circadian rhythm, and overall reduces the
severity of brain damage in experimental models of ICH
(54–56). Further studies are needed to understand whether
the beneficial effect of CO on ICH-induced brain damage
relies on its ability to prevent oxidation of cell-free Hb and
subsequent heme release.
Adhesion molecules mediate the inflammatory cell response
to injury through adherence to the vascular endothelium,
diapedesis through the endothelial barrier, and migration into
the tissues. Normally, vascular endothelium is in a quiescent
state characterized by low expression of adhesion molecules.
In contrast, upon insult, endothelial dysfunction develops,
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characterized by elevated expression of adhesion molecules and
pro-inflammatory cytokines. Brain hemorrhage triggers a local
inflammatory response, and consequently, the levels of soluble
adhesion molecules (i.e., E-selectin, ICAM-1, VCAM-1, and
L-selectin) and inflammatory cytokines are elevated in the CSF of
patients after subarachnoid hemorrhage (8, 57). IVH is followed
by a systemic inflammatory response as well, and the extent of
this response seems to be associated with white matter injury
(7). ICAM-1 is a potential therapeutic target to attenuate cerebral
vasospasm after subarachnoid hemorrhage (58).
Heme and oxidized Hb forms (i.e., metHb and ferrylHb)
have been previously shown to induce adhesion molecules as
well as pro-inflammatory cytokines (e.g., IL-6, IL-8, IL-1β)
in human umbilical vein ECs (16, 59–61). Here we showed
that heme and ferrylHb are the most potent inducers of the
expression of adhesion molecules and IL-8 in BMECs, and that
the levels of VCAM-1, ICAM-1, and IL-8 in CSF gradually
decreased following the onset of IVH and correlated to total heme
concentration of CSF.
Overall our study suggests that RBC destruction, Hb
oxidation, and heme release are important pathogenic factors in
IVH. On the other hand, this work also has some limitations.
The study examined a very fragile group of patients: preterm
babies with IVH grade III. The work is based on the examination
of CSF samples obtained for diagnostic purposes; therefore, we
could not influence the time of sampling. The earliest time point
when we obtained CSF was day 14 after the onset of IVH,
leaving us without information about the critically important
first 2 weeks following IVH. We can speculate that in the first
2 weeks after IVH, we could have seen even higher amounts
of Hb and its derivatives in the CSF. Another limitation of this
work is that we have focused on only Hb and its derivatives,
although it is very likely that the IVH-associated inflammatory
response is much more complex. The major determinant of the
inflammatory response and the outcome of IVH is the volume
of bleeding, which likely correlates with the levels of Hb and its
derivatives in the CSF. Despite these limitations, we believe that
extracellular Hb and its derivatives contribute to the pathogenesis
of IVH and pharmacological interventions targeting extracellular
Hb, Hb oxidation, and heme could have a potential to limit the
neuroinflammatory response following IVH.
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